Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Adverum Biotechnologies stock | $3.46
Learn how to easily invest in Adverum Biotechnologies stock.
Adverum Biotechnologies, Inc is a biotechnology business based in the US. Adverum Biotechnologies shares (ADVM) are listed on the NASDAQ and all prices are listed in US Dollars. Adverum Biotechnologies employs 167 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Adverum Biotechnologies
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADVM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Adverum Biotechnologies stock price (NASDAQ: ADVM)Use our graph to track the performance of ADVM stocks over time.
Adverum Biotechnologies shares at a glance
|Latest market close||$3.46|
|52-week range||$2.29 - $19.25|
|50-day moving average||$3.32|
|200-day moving average||$7.73|
|Wall St. target price||$7.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.05|
Buy Adverum Biotechnologies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Adverum Biotechnologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adverum Biotechnologies price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||-2.54%|
|3 months (2021-05-03)||-6.99%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Adverum Biotechnologies financials
|Revenue TTM||$7.5 million|
|Gross profit TTM||$-73,309,000|
|Return on assets TTM||-18.95%|
|Return on equity TTM||-34.24%|
|Market capitalisation||$236.5 million|
TTM: trailing 12 months
Shorting Adverum Biotechnologies shares
There are currently 11.2 million Adverum Biotechnologies shares held short by investors – that's known as Adverum Biotechnologies's "short interest". This figure is 31.2% up from 8.5 million last month.
There are a few different ways that this level of interest in shorting Adverum Biotechnologies shares can be evaluated.
Adverum Biotechnologies's "short interest ratio" (SIR)
Adverum Biotechnologies's "short interest ratio" (SIR) is the quantity of Adverum Biotechnologies shares currently shorted divided by the average quantity of Adverum Biotechnologies shares traded daily (recently around 2.2 million). Adverum Biotechnologies's SIR currently stands at 5.04. In other words for every 100,000 Adverum Biotechnologies shares traded daily on the market, roughly 5040 shares are currently held short.
However Adverum Biotechnologies's short interest can also be evaluated against the total number of Adverum Biotechnologies shares, or, against the total number of tradable Adverum Biotechnologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adverum Biotechnologies's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Adverum Biotechnologies shares in existence, roughly 110 shares are currently held short) or 0.177% of the tradable shares (for every 100,000 tradable Adverum Biotechnologies shares, roughly 177 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Adverum Biotechnologies.
Find out more about how you can short Adverum Biotechnologies stock.
Adverum Biotechnologies share dividends
We're not expecting Adverum Biotechnologies to pay a dividend over the next 12 months.
Adverum Biotechnologies share price volatility
Over the last 12 months, Adverum Biotechnologies's shares have ranged in value from as little as $2.29 up to $19.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adverum Biotechnologies's is 1.1861. This would suggest that Adverum Biotechnologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Adverum Biotechnologies overview
Adverum Biotechnologies, Inc. , a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc.
Stocks similar to Adverum Biotechnologies
Adverum Biotechnologies in the news
Stocks That Hit 52-Week Lows On Monday
75 Biggest Movers From Friday
50 Stocks Moving In Friday's Mid-Day Session
Frequently asked questionsWhat percentage of Adverum Biotechnologies is owned by insiders or institutions?
Currently 0.809% of Adverum Biotechnologies shares are held by insiders and 100.094% by institutions. How many people work for Adverum Biotechnologies?
Latest data suggests 167 work at Adverum Biotechnologies. When does the fiscal year end for Adverum Biotechnologies?
Adverum Biotechnologies's fiscal year ends in December. Where is Adverum Biotechnologies based?
Adverum Biotechnologies's address is: 800 Saginaw Drive, Redwood City, CA, United States, 94063 What is Adverum Biotechnologies's ISIN number?
Adverum Biotechnologies's international securities identification number is: US00773U1088 What is Adverum Biotechnologies's CUSIP number?
Adverum Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 00773U108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert